<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">2. Recent Progress of Antiprotozoan Agents</segment>
<segment id="2" parent="1002" relname="preparation">2.1. Anti-Giardiasis</segment>
<segment id="3" parent="1004" relname="span">Giardiasis is caused by the protozoan parasite G. intestinalis</segment>
<segment id="4" parent="3" relname="elaboration">( also known as G. lamblia or G. duodenalis ) .</segment>
<segment id="5" parent="1005" relname="span">It is also known by the common name “ beaver fever , ”</segment>
<segment id="6" parent="1006" relname="span">because this infection was reported in campers</segment>
<segment id="7" parent="1007" relname="span">who drank contaminated water</segment>
<segment id="8" parent="7" relname="elaboration">that was inhabited by beavers .</segment>
<segment id="9" parent="1002" relname="joint">Giardiasis is the most common protozoan infection in human beings ,</segment>
<segment id="10" parent="1002" relname="joint">and it occurs in both developing and industrialized countries .</segment>
<segment id="11" parent="1011" relname="span">Its global incidence is believed to range between 20 % – 60 % ,</segment>
<segment id="12" parent="11" relname="elaboration">with 2 % – 7 % incidence in industrialized nations .</segment>
<segment id="13" parent="1013" relname="span">Giardia intestinalis was first described in 1681</segment>
<segment id="14" parent="13" relname="circumstance">after the Dutch microscopist Antonie van Leeuwenhoek observed the protozoan in his own diarrheic stools .</segment>
<segment id="15" parent="1015" relname="span">This disease is often prevalent in poor countries and communities</segment>
<segment id="16" parent="15" relname="elaboration">that have untreated water , inadequate sanitation , and poor dietary status .</segment>
<segment id="17" parent="1002" relname="joint">The infection is caused by fecal – oral transmission</segment>
<segment id="18" parent="1002" relname="joint">and initiated by the ingestion of infectious cysts from contaminated water or through person-to-person contact .</segment>
<segment id="19" parent="1019" relname="span">After excystation , flagellated trophozoites colonize the upper small intestine ,</segment>
<segment id="20" parent="1020" relname="contrast">where they attach to the epithelial lining</segment>
<segment id="21" parent="1020" relname="contrast">but do not invade the mucosa .</segment>
<segment id="22" parent="23" relname="concession">The duration of Giardia infection is variable ;</segment>
<segment id="23" parent="1022" relname="span">however , chronic infection and reinfection commonly occur .</segment>
<segment id="24" parent="1025" relname="span">Approximately 50 % of the symptoms classically associated with giardiasis are asymptomatic</segment>
<segment id="25" parent="24" relname="elaboration">including diarrhea , abdominal pain , nausea , vomiting , and anorexia .</segment>
<segment id="26" parent="1026" relname="span">However , infected individuals can also develop extraintestinal and postinfectious complications .</segment>
<segment id="27" parent="28" relname="concession">Chronic extraintestinal sequelae may affect the joints , skin , eyes , and central nervous system ,</segment>
<segment id="28" parent="1028" relname="span">but the underlying mechanisms are unknown .</segment>
<segment id="29" parent="1031" relname="span">According to research data , Giardia has eight distinct genetic assemblages</segment>
<segment id="30" parent="29" relname="elaboration">labelled as assemblage “ A ” through “ H ” ,</segment>
<segment id="31" parent="1030" relname="joint">and assemblages “ A ” and “ B ” are responsible for infection in humans .</segment>
<segment id="32" parent="33" relname="preparation">Three classes of drugs are currently used for the treatment of giardiasis :</segment>
<segment id="33" parent="1032" relname="span">metronidazole , mepacrine analogs , and nitrofurans , such as furazolidone (</segment>
<segment id="34" parent="1034" relname="preparation">Figure 1</segment>
<segment id="35" parent="1035" relname="preparation">) .</segment>
<segment id="36" parent="1035" relname="joint">Metronidazole is the most widely used drug for the treatment of giardiasis globally</segment>
<segment id="37" parent="1035" relname="joint">and it is generally effective and well-tolerated .</segment>
<segment id="38" parent="1038" relname="span">However , the United States Food and Drug Administration</segment>
<segment id="39" parent="38" relname="elaboration">( FDA ) has not yet approved this drug for the treatment of Giardia infection</segment>
<segment id="40" parent="1040" relname="joint">because of its toxicity and major side effects , such as seizures , ataxia , peripheral neuropathy , transient myopia , gastric mucosal irritation , sperm damage , and hematuria .</segment>
<segment id="41" parent="1041" relname="span">Tinidazole is an N1-position modified 5-nitro imidazole ,</segment>
<segment id="42" parent="41" relname="elaboration">which has been approved by the FDA for the treatment of giardiasis .</segment>
<segment id="43" parent="1043" relname="span">Nitazoxanide</segment>
<segment id="44" parent="43" relname="elaboration">( NTZ ) belongs to an emerging class of 5-nitrothiazole compounds with potential antigiardial activity .</segment>
<segment id="45" parent="1045" relname="same_unit">However ,</segment>
<segment id="46" parent="47" relname="concession">although NTZ is generally well tolerated ,</segment>
<segment id="47" parent="1046" relname="span">some adverse effects such as abdominal pain , diarrhea , and nausea limit the safe use for human beings .</segment>
<segment id="48" parent="1047" relname="joint">Mepacrine is no longer available in the United States ,</segment>
<segment id="49" parent="1048" relname="joint">and it is being replaced in most of its applications with safer and more specific drugs .</segment>
<segment id="50" parent="1050" relname="span">Furazolidone also has serious side effects , such as gastrointestinal disturbances , hemolytic anemia , disulfiram-like reactions to alcohol , and hypersensitivity reactions , as well as evidence of tumorigenicity in rodent studies .</segment>
<segment id="51" parent="50" relname="elaboration">Furthermore , G. lamblia resistance to this drug has also been reported .</segment>
<segment id="52" parent="1052" relname="span">Therefore , research</segment>
<segment id="53" parent="52" relname="elaboration">focusing on the development of novel , alternative drugs for the treatment of giardiasis is highly desirable .</segment>
<segment id="54" parent="1053" relname="joint">In view of these considerations ,</segment>
<segment id="55" parent="1054" relname="span">researchers have designed and synthesized some novel molecules</segment>
<segment id="56" parent="1055" relname="span">for the treatment of giardiasis ,</segment>
<segment id="57" parent="56" relname="elaboration">their results are summarized in Table 1 .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1004" type="span" parent="1002" relname="joint"/>
<group id="1005" type="span" parent="1002" relname="joint"/>
<group id="1006" type="span" parent="5" relname="cause"/>
<group id="1007" type="span" parent="6" relname="elaboration"/>
<group id="1011" type="span" parent="1002" relname="joint"/>
<group id="1013" type="span" parent="1002" relname="joint"/>
<group id="1015" type="span" parent="1002" relname="joint"/>
<group id="1019" type="span" parent="1002" relname="joint"/>
<group id="1020" type="multinuc" parent="19" relname="elaboration"/>
<group id="1022" type="span" parent="1002" relname="joint"/>
<group id="1023" type="span" parent="1002" relname="joint"/>
<group id="1024" type="multinuc" parent="1033" relname="preparation"/>
<group id="1025" type="span" parent="1024" relname="contrast"/>
<group id="1026" type="span" parent="1024" relname="contrast"/>
<group id="1027" type="multinuc" parent="26" relname="elaboration"/>
<group id="1028" type="span" parent="1027" relname="joint"/>
<group id="1029" type="multinuc" parent="1027" relname="joint"/>
<group id="1030" type="multinuc" parent="1029" relname="joint"/>
<group id="1031" type="span" parent="1030" relname="joint"/>
<group id="1032" type="span" parent="1029" relname="joint"/>
<group id="1033" type="span" parent="1023" relname="span"/>
<group id="1034" type="span" parent="1033" relname="span"/>
<group id="1035" type="multinuc" parent="1034" relname="span"/>
<group id="1037" type="span" parent="1035" relname="joint"/>
<group id="1038" type="span" parent="1037" relname="span"/>
<group id="1039" type="multinuc" parent="1038" relname="cause"/>
<group id="1040" type="multinuc" parent="1039" relname="joint"/>
<group id="1041" type="span" parent="1040" relname="joint"/>
<group id="1042" type="multinuc" parent="1039" relname="joint"/>
<group id="1043" type="span" parent="1042" relname="contrast"/>
<group id="1044" type="multinuc" parent="1042" relname="contrast"/>
<group id="1045" type="multinuc" parent="1044" relname="joint"/>
<group id="1046" type="span" parent="1045" relname="same_unit"/>
<group id="1047" type="multinuc" parent="1044" relname="joint"/>
<group id="1048" type="multinuc" parent="1047" relname="joint"/>
<group id="1049" type="multinuc" parent="1048" relname="joint"/>
<group id="1050" type="span" parent="1049" relname="joint"/>
<group id="1051" type="span" parent="1049" relname="joint"/>
<group id="1052" type="span" parent="1053" relname="preparation"/>
<group id="1053" type="multinuc" parent="1051" relname="span"/>
<group id="1054" type="span" parent="1053" relname="joint"/>
<group id="1055" type="span" parent="55" relname="purpose"/>
	</body>
</rst>
